Acetylation of Starch Extracted from Rejected Fruits of Musa × paradisiaca L. to Obtain a Pharmaceutical Disintegrant

Karla Dumancela, E. Mayorga, J. Aguirre
{"title":"Acetylation of Starch Extracted from Rejected Fruits of Musa × paradisiaca L. to Obtain a Pharmaceutical Disintegrant","authors":"Karla Dumancela, E. Mayorga, J. Aguirre","doi":"10.4236/pp.2020.116011","DOIUrl":null,"url":null,"abstract":"There are many natural sources to obtain \npharmaceutical grade starch, one of which is banana (Musa × paradisiaca L.); nevertheless, the use of native starch \nhas certain disadvantages compared to modified starches, whose disintegrating \nproperties are better. In this study, starch extracted from rejected fruits of Musa × paradisiaca L., was modified by acetylation, under the \nfollowing optimized experimental conditions: 130 mL acetic anhydride, 3 mL \nsodium hydroxide 50% p/v for each 15 grams of native starch, at 123℃ during 3 \nhours. The reaction resulted in a modified green banana starch with twice as \nmuch swelling capacity compared to unmodified (native) starch; acetylation was \nverified by infrared spectroscopy and degree of substitution of acetyl groups by \nback titration. The dissolution profiles of Ibuprofen tablets made with banana modified starch and commercial disintegrant, \nhave no differences according with their similarity factor, f2. It is concluded that it is feasible to use green \nbanana starch modified through acetylation as a pharmaceutical disintegrant.","PeriodicalId":20031,"journal":{"name":"Pharmacology & Pharmacy","volume":"17 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology & Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4236/pp.2020.116011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

There are many natural sources to obtain pharmaceutical grade starch, one of which is banana (Musa × paradisiaca L.); nevertheless, the use of native starch has certain disadvantages compared to modified starches, whose disintegrating properties are better. In this study, starch extracted from rejected fruits of Musa × paradisiaca L., was modified by acetylation, under the following optimized experimental conditions: 130 mL acetic anhydride, 3 mL sodium hydroxide 50% p/v for each 15 grams of native starch, at 123℃ during 3 hours. The reaction resulted in a modified green banana starch with twice as much swelling capacity compared to unmodified (native) starch; acetylation was verified by infrared spectroscopy and degree of substitution of acetyl groups by back titration. The dissolution profiles of Ibuprofen tablets made with banana modified starch and commercial disintegrant, have no differences according with their similarity factor, f2. It is concluded that it is feasible to use green banana starch modified through acetylation as a pharmaceutical disintegrant.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
天麻废果淀粉乙酰化制备药用崩解剂的研究
药用级淀粉有许多天然来源,其中之一是香蕉(Musa × paradisiaca L.);然而,与降解性能更好的改性淀粉相比,使用天然淀粉有一定的缺点。本研究采用乙酰化改性法,对天麻废果中提取的淀粉进行改性,优化实验条件为:醋酸酐130 mL,氢氧化钠3 mL,每15 g天然淀粉50% p/v,温度123℃,时间3小时。该反应产生的改性绿香蕉淀粉的膨胀能力是未改性(天然)淀粉的两倍;用红外光谱和反滴定法对乙酰化反应进行了验证。香蕉变性淀粉与市售崩解剂的布洛芬片溶出度曲线按相似系数f2计算无差异。结果表明,采用乙酰化改性青香蕉淀粉作为药物崩解剂是可行的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Quantitative determination of total flavonoids in Glycyrrhiza Glabra L. herbs New role of extemporaneous manufacturing in regulating drug products access onto the market “Off-label” drugs: legal problems and socio-economic aspects of application practice Analysis of cytokine response characteristics and immunopathogenetic effects of double-stranded sodium salt RNA-based drug for postexposure prophylaxis against novel coronavirus infection: double-blind, placebo-controlled trial Development of composition and technology for obtaining antimicrobial composition based on mono- and sesquiterpenoids
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1